Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study

BACKGROUND: Recent research has shown that selected patients with initially unresectable hepatocellular carcinoma (HCC) are able to achieve conversion to resectable disease through systemic or local therapy. Combination regimens comprised of drugs with different mechanisms of action have shown bette...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinliang, Zhang, Xihao, Mu, Han, Yu, Ge, Xing, Wenge, Wang, Lu, Zhang, Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632765/
https://www.ncbi.nlm.nih.gov/pubmed/34868921
http://dx.doi.org/10.3389/fonc.2021.729764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632765/
https://www.ncbi.nlm.nih.gov/pubmed/34868921
http://dx.doi.org/10.3389/fonc.2021.729764

Ejemplares similares